Date: Tue 02/02/2021 - Thu 02/02/2023
Optometrist Credits: 0.50 Clinical Diagnostic Credits
Event Type(s): Online
Number: 09 929 3273
In Australia and New Zealand MiSight 1 day has been approved for correcting and controlling the progression of myopia. The US Food & Drug Administration approved the lens most recently, joining Canada and several countries in Europe, the Middle East and Asia.
This article provides clinical insights and strategies to help eye care professionals incorporate MiSight 1 day contact lenses into their treatment plan for their young patients with myopia.
On completion of this CPD activity, you should be able to:
1. Understand the lifetime risks of vision impairment associated with high myopia compared to contact lens-associated microbial keratitis,
2. Be prepared to communicate key messages about contact lenses for myopia management to parents, and
3. Be familiar with lens handling experiences and reactions of children prescribed MiSight 1 day.